Company intelligence / Profile preview

Teknova

Hollister, California, United Statesteknova.com ↗

Ownership: Public · TKNO
Employees: ~173
Development stage: Commercial

Overview

Teknova manufactures critical reagents for the life sciences industry, supporting cell and gene therapy, molecular diagnostics, and synthetic biology with both research-use-only (RUO) and GMP products.

Modalities: Custom reagentscell culture mediabuffersmolecular biology reagents
Industry: Chemicals & Materials

Partnerships

Pluristyx (collaboration on PluriFreeze™ Cryopreservation System)

Financials

Market cap: $368.9M
Total revenue: $12.2M
Enterprise value: $378.8M

Beyond the preview

Go deeper on Teknova.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Teknova.

Explore the full profile